Yakult announces entry into biosimilars in joint venture with UMN Pharma and API, an OECM company in Gifu

The focus will be on the development of carcinostatic substances

Yakult press release, March 6, 2013

Yakult announces entry into biosimilars in joint venture with UMN Pharma and API, an OECM company in Gifu
Scroll to top